Dynamics of resistance mutations to NS3 protease inhibitors in a cohort of Brazilian patients chronically infected with hepatitis C virus (genotype 1) treated with pegylated interferon and ribavirin: a prospective longitudinal study

ABSTRACT: About sixty thousand new cases of Hepatitis C virus (HCV) infection are recorded in Brazil each year. These cases are currently treated with pegylated interferon (PEG-IFN) and ribavirin (RBV) with an overall success rate of 50%. New compounds for anti-HCV therapy targeted to the HCV NS3 pr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hoffmann, Luísa, Ramos, Juliene Antonio, de Souza, Elizabeth Valentin, de Araújo Ramos, Ana Lucia, Villela-Nogueira, Cristiane Alves, Ürményi, Turán Péter, Tanuri, Amilcar, Rondinelli, Edson, Silva, Rosane
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2013
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3599441/
https://ncbi.nlm.nih.gov/pubmed/23409973
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1743-422X-10-57
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados